Search research articles
Contact Us
Filters
Showing results (1-10 of 157) with videos related to
Page
of 16
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
May 12, 2009
Protecting the blood supply from emerging pathogens: the role of pathogen inactivation
M A Blajchman
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
January 1, 1994
An overview of the mechanism of action of antithrombin and its inherited deficiency states
M A Blajchman
Developments in Biologicals
|
May 4, 2000
Reducing the risk of bacterial contamination of cellular blood components
M A Blajchman
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
August 14, 2001
Novel platelet products, substitutes and alternatives
M A Blajchman
Hematology (Amsterdam, Netherlands)
|
September 29, 2005
Transfusion immunomodulation or TRIM: what does it mean clinically?
M A Blajchman
Immunological Investigations
|
January 1, 1995
Bacterial contamination of blood products and the value of pre-transfusion testing
M A Blajchman
Journal of Thrombosis and Haemostasis : JTH
|
July 23, 2003
Substitutes and alternatives to platelet transfusions in thrombocytopenic patients
M A Blajchman
Developments in Biologicals
|
September 11, 2002
Incidence and significance of the bacterial contamination of blood components
M A Blajchman
Vox Sanguinis
|
August 12, 2000
Platelet substitutes
M A Blajchman
The Journal of Trauma
|
June 10, 2006
The clinical benefits of the leukoreduction of blood products
M A Blajchman
Page
of 16
Search research articles
Search
Showing results (1-10 of 157) with videos related to
Sort By:
Page
of 16
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
May 12, 2009
Protecting the blood supply from emerging pathogens: the role of pathogen inactivation
M A Blajchman
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
January 1, 1994
An overview of the mechanism of action of antithrombin and its inherited deficiency states
M A Blajchman
Developments in Biologicals
|
May 4, 2000
Reducing the risk of bacterial contamination of cellular blood components
M A Blajchman
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
August 14, 2001
Novel platelet products, substitutes and alternatives
M A Blajchman
Hematology (Amsterdam, Netherlands)
|
September 29, 2005
Transfusion immunomodulation or TRIM: what does it mean clinically?
M A Blajchman
Immunological Investigations
|
January 1, 1995
Bacterial contamination of blood products and the value of pre-transfusion testing
M A Blajchman
Journal of Thrombosis and Haemostasis : JTH
|
July 23, 2003
Substitutes and alternatives to platelet transfusions in thrombocytopenic patients
M A Blajchman
Developments in Biologicals
|
September 11, 2002
Incidence and significance of the bacterial contamination of blood components
M A Blajchman
Vox Sanguinis
|
August 12, 2000
Platelet substitutes
M A Blajchman
The Journal of Trauma
|
June 10, 2006
The clinical benefits of the leukoreduction of blood products
M A Blajchman
Page
of 16